![Dennis Dalangin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dennis Dalangin
Vorstandsvorsitzender bei Critical Care Diagnostics, Inc.
Profil
Dennis Dalangin is currently the Chief Executive Officer at Critical Care Diagnostics, Inc. He started this position in 2018.
Prior to his current role, he worked at Critical Care Diagnostics, Inc. since 2012.
Mr. Dalangin completed his undergraduate degree at Westmont College.
Aktive Positionen von Dennis Dalangin
Unternehmen | Position | Beginn |
---|---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.01.2018 |
Ausbildung von Dennis Dalangin
Westmont College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Critical Care Diagnostics, Inc.
![]() Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |